Biodesix raises ~$16.3M via ATM equity sale, repays $20M of term loan with SVB

BIODESIX INC

Raised ~$16.3M from sale of 3,756,994 common shares in ATM offering on Dec 30, 2021.
Entered Consent and Second Amendment to $30M 2021 Term Loan with Silicon Valley Bank on Dec 31, 2021.
Repaid $20M in outstanding principal on Dec 31; $600,000 prepayment fee waived.
Amendment consents to $4.6M milestone payment under Integrated Diagnostics APA in Jan 2022.
Company cites improved financial flexibility to advance strategic growth objectives.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.